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Abstract 16 – Figure 2. Results from a genome-wide linkage scan using 124 families with 334 patients with total knee replacement associated with OA.
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GENOME-WIDE ASSOCIATION SCAN OF
OSTEOARTHRITIS OF THE KNEE
A.M. Valdes1, K. Timms2, E. Mitchell3, A. Nessa1, D. Hart1,
G. Surdulescu1, A. Gutin2, V. Abkevich2, M. Doherty3,
J.S. Lanchbury2, T.D. Spector1
1King’s College London, St Thomas Hospital, London, United
Kingdom; 2Myriad Genetics Inc, Salt Lake City, UT; 3University
of Nottingham, Nottingham, United Kingdom
Purpose: Osteoarthritis (OA) of the knee has an increasing
public health impact in aging populations. Combinations of genes
have shown potential to identify individuals at high risk of disease.
However, to date the discovery of novel genetic risk factors for
knee OA using large-scale genome-wide association methods
has not been undertaken.
Methods: In this study the allele frequencies of 550,000 mark-
ers from the HumanHap550 Whole-Genome Genotyping from
pooled genomic DNA from 713 female knee OA cases and 569
controls were calculated. Data for markers in common with the
HumanHap300-Duo Genotyping BeadChip were combined with
individual genotypes for 100 knee OA cases and 500 controls
(all female).
Results: Preliminary analyses indicated that genes part of pro-
apoptotic signaling, in the Wnt signaling and Smad signaling
pathways that had not previously shown to be involved in OA
were associated with disease risk. For the ten markers with
the smallest p-values, all showing genome-wide signiﬁcance,
two or more SNPs in the same gene region were selected and
genotyped individually for the original 813 cases plus additional
540 cases and for the original 1069 controls plus additional 1040
controls.
Conclusions: We present the combined results of the discovery
and replication samples in the largest genetic association study
of knee OA in women to date.
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ASSOCIATION OF GDF5 WITH OSTEOARTHRITIS AND
ITS MOLECULAR PATHOGENESIS
S. Ikegawa1, T. Furuichi1, Y. Miyamoto1, A. Mabuchi1,
H. Masuya2, S. Wakana2, D. Shi3, Q. Jiang3
1SRC RIKEN, Tokyo, Japan; 2GSC RIKEN, Tokyo, Japan; 3Drum
Tower Hospital Afﬁliated to Medical School of Nanjing University,
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Purpose: Osteoarthritis (OA) is the most common bone and
joint disease. Genetic factors have been implicated in its etiology
and pathogenesis. Growth and differentiation factor 5 (GDF5)
is a growth factor that belongs to a subgroup of the TGF-
β/BMP family. GDF5 has been implicated in chondrogenesis,
joint formation and OA. The aim of the study is to clarify the role
of GDF5 in the etiology and pathogenesis of OA using combined
approach of human and mouse genetics.
Methods: Human study. A case-control association study on
GDF5 was performed for OA of the knee and hip joints in
Japanese using several independent cohorts including a total
of more than 3,500 subjects (1,000 hip OA, 718 knee OA and
1,845 control). A susceptibility gene was located by a linkage-
disequilibrium mapping. The replication of the association was
examined in a Han Chinese knee OA population. The allelic
difference of the associated sequence variation was evaluated
by in vitro functional studies.
Mouse study. Through a large-scale ENU mutagenesis screen,
a mouse mutant with Gdf5 mutation was identiﬁed. This mouse
carries an amino acid substitution (W408R) in a highly conserved
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region of the signaling domain of Gdf5 protein. The phenotype
of the mouse was characterized by radiographic and histological
examination. The mechanism of the mutation was examined in
vitro using recombinant Gdf5s.
Results: Human study. GDF5 is associated with OA. A single
nucleotide polymorphism (SNP) in its 5’-UTR (+104T/C) showed
a signiﬁcant association (P=1.8 x 10-13; odds ratio= 1.8) in two
independent hip OA populations. This association was replicated
for knee OA in Japanese and Chinese. Located in the GDF5
core promoter, this SNP exerted allelic differences on transcrip-
tional activity in chondrogenic cells, with the susceptibility allele
showing reduced transcriptional activity.
Mouse study. The mutation is semi-dominant, showing brachy-
podism and digit ankylosis in heterozygotes, and much more
severe brachypodism, ankylosis of the knee, and early-onset OA
of the elbow in homozygotes. The mutant GDF5 protein was
secreted and dimerizes normally, but did not induce BMP signal
nor cartilage matrix gene expression. It inhibited the function of
the wild-type Gdf5 protein in a dominant-negative fashion.
Conclusions: GDF5 is a susceptibility gene for OA. Decrease
of GDF5 is involved in OA pathogenesis and impairs joint main-
tenance. The Gdf5 mutant mouse would serve as a good model
for OA.
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A SNP IN THE 5’ UTR OF GDF5 IS ASSOCIATED WITH
OSTEOARTHRITIS SUSCEPTIBILITY IN EUROPEANS
AND WITH IN VIVO DIFFERENCES IN ALLELIC
EXPRESSION IN ARTICULAR CARTILAGE
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Purpose: A compelling genetic association with OA of a func-
tional SNP (rs143383, T/C) in the 5’ UTR of the GDF5 gene was
recently reported in case-control cohorts from Japan and China.
GDF5 is a pro-chondrogenic growth factor. The T-allele frequency
of the gene was elevated in cases, with an odds ratio (OR) of
1.79, and in vitro functional studies demonstrated that this allele
mediated a moderate but signiﬁcant reduction in the activity of
the GDF5 promoter in several cell lines. Our objectives were to
assess whether the SNP was also associated with OA in a broad
European population and to assess the functional effect of the
SNP on GDF5 allelic expression using RNA extracted from the
cartilage of OA patients who had undergone joint-replacement
surgery.
Methods: The SNP was genotyped in 2487 OA patients (cases)
ascertained by the need for joint replacement surgery of the hip
or knee and in 2018 age-matched controls. RNA was extracted
from the articular cartilage of 9 OA patients who were heterozy-
gous at the SNP and was used to measure allelic expression
by a single base-pair extension assay that can discriminate and
quantify the mRNA synthesised from each allele.
Results: The T-allele was associated with OA (P = 0.03, OR
= 1.10) as was carrier status for this allele (P = 0.004, OR =
1.28). The associated T-allele showed up to a 27% reduction in
expression relative to the C-allele in OA cartilage (P = 0.00007).
Conclusions: Our study supports the Asian report and high-
lights GDF5 as a globally relevant OA susceptibility locus. The
functional difference mediated by SNP rs143383 on GDF5 ex-
pression is active in patients who have severe end stage disease
up to the point at which they require surgery, implying that a
small but persistent imbalance of GDF5 expression throughout
life renders an individual more susceptible to OA.
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INCREASED RISK OF OSTEOARTHRITIS
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Purpose: To examine the relationship between common genetic
variation of the ESR2 gene and radiographic hand-, knee-, hip-
and generalized osteoarthritis (ROA) in two large population-
based cohorts: the Rotterdam Study and the Chingford Study.
Methods: In total, 5222 subjects had data available on genotype
and ROA outcomes. ROA was deﬁned as a Kellgren/Lawrence
score (K/L score) ≥2. Seven tagging SNPs were genotyped in
the Rotterdam Study and one of these SNPs, rs1256031, was
genotyped in the Chingford Study.
Results: In the Rotterdam Study, female homozygote carriers
of the C allele of the rs1256031 SNP (htSNP2) had an 84% in-
creased risk for hip OA (95% CI 1.17-2.87, p=0.008) and an 80%
increased risk for generalized OA (95% CI 1.15-2.82, p=0.01).
A 100% increased risk was observed for progression of hip OA
(95% CI 1.24-3.23, p=0.005) and a non-signiﬁcant trend towards
higher levels of CTX-II was observed. Similar trends were seen
in the Chingford Study, where an increased risk for hip-, knee-
and progression of hip OA and higher CTX-II levels were ob-
served, although not signiﬁcant. Four common haplotypes were
inferred from 7 tagging SNPs. Haplotype analysis conﬁrmed the
associations observed with single SNP analysis.
Conclusions: Female carriers of the C allele of the rs1256031
SNP of the ESR2 gene have an increased risk of OA. This SNP
is in high linkage disequilibrium with 21 other SNPs, including 18
potential functional variants that could explain the increased risk
for OA. This study showed that common genetic variation in the
ESR2 gene inﬂuences the risk of osteoarthritis.
